UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial

Breast (Edinburgh), 2024-06, Vol.75, p.103725-103725, Article 103725

2024

Link zum Volltext

Verfügbarkeit prüfen

SnapShot: Cancer chemotherapy

Cell, 2023-04, Vol.186 (8), p.1816-1816.e1

2023

Link zum Volltext

Verfügbarkeit prüfen

Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study

Lung cancer (Amsterdam, Netherlands), 2005-11, Vol.50 (2), p.247-254

2005

Link zum Volltext

Verfügbarkeit prüfen

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

The lancet oncology, 2020-04, Vol.21 (4), p.497-507

2020

Link zum Volltext

Verfügbarkeit prüfen

Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity

Critical reviews in oncology/hematology, 2021-11, Vol.167, p.103501-103501, Article 103501

2021

Link zum Volltext

Verfügbarkeit prüfen

Second medical opinion in oncological setting

Critical reviews in oncology/hematology, 2021-04, Vol.160, p.103282-103282, Article 103282

2021

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial

The lancet oncology, 2005-06, Vol.6 (6), p.369-376

2005

Link zum Volltext

Verfügbarkeit prüfen

Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?

Journal of geriatric oncology, 2021-01, Vol.12 (1), p.163-167

2021

Link zum Volltext

Verfügbarkeit prüfen

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Clinical colorectal cancer, 2018-09, Vol.17 (3), p.e457-e470

2018

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

Clinical colorectal cancer, 2020-06, Vol.19 (2), p.109-115

2020

Link zum Volltext

Verfügbarkeit prüfen

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial

European journal of cancer (1990), 2004-07, Vol.40 (11), p.1682-1688

2004

Link zum Volltext

Verfügbarkeit prüfen

Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study

Journal of geriatric oncology, 2019-07, Vol.10 (4), p.591-597

2019

Link zum Volltext

Verfügbarkeit prüfen

A new informed consent form model for cancer patients: Preliminary results of a prospective study by the Italian Association of Medical Oncology (AIOM)

Patient education and counseling, 2012-05, Vol.87 (2), p.243-249

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2004-05, Vol.44 (2), p.231-239

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2006-03, Vol.51 (3), p.357-362

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience

Clinical colorectal cancer, 2006-03, Vol.5 (6), p.422-428

2006

Link zum Volltext

Verfügbarkeit prüfen

P-5 A phase II trial of paclitaxel carboplatin and gemcitabine as induction chemotherapy for stage III NSCLC

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S92-S92

2003

Link zum Volltext

Verfügbarkeit prüfen

P-214 Long-term remissions induced by oral temozolomide in progressive, pre-radiotherapy treated brain recurrences from non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S145-S145

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Oncology
(16)
Humans
(14)
Aged
(12)
Female
(12)
Male
(11)
Middle Aged
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Adult
(7)
Treatment Outcome
(6)
Biological And Medical Sciences
(5)
Cancer
(5)
Medical Sciences
(5)
Survival Analysis
(5)
Adenocarcinoma - Drug Therapy
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Colorectal Neoplasms - Drug Therapy
(4)
Colorectal Neoplasms - Pathology
(4)
Disease-Free Survival
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial

SnapShot: Cancer chemotherapy

Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity

Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy—a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest

Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

Second medical opinion in oncological setting

Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial

Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial

Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study

Rationale and Design of MILES-3 and MILES-4 Studies: Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

A new informed consent form model for cancer patients: Preliminary results of a prospective study by the Italian Association of Medical Oncology (AIOM)

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience

P-5 A phase II trial of paclitaxel carboplatin and gemcitabine as induction chemotherapy for stage III NSCLC

P-214 Long-term remissions induced by oral temozolomide in progressive, pre-radiotherapy treated brain recurrences from non-small cell lung cancer

Aktive Filter

Suchergebnisse filtern